Drugs Made In America Acquisition (DMIIR) Liabilities and Shareholders Equity (2024 - 2025)
Drugs Made In America Acquisition's (DMIIR) quarterly Liabilities and Shareholders Equity came in at $505.0 million in Q4 2025, up 365643.31% year-on-year from N/an in Q4 2024, and up 0.79% on a QoQ basis from $501.0 million in Q3 2025.
Drugs Made In America Acquisition (DMIIR) Liabilities and Shareholders Equity (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has 2 years of Liabilities and Shareholders Equity data on file, last reported at $505.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 480.75 Mn | 480.75 Mn | - | 474.42 Mn |
| 2 | Agriculture & Natural Solutions Acquisition | 393.29 Mn | 393.29 Mn | - | 366.18 Mn |
| 3 | Berto Acquisition | 314.56 Mn | 314.35 Mn | - | 311.76 Mn |
| 4 | GP-Act III Acquisition | 313.66 Mn | 313.66 Mn | - | 309.37 Mn |
| 5 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | 310.95 Mn |
| 6 | Republic Digital Acquisition | 310.50 Mn | 309.63 Mn | - | 311.78 Mn |
| 7 | Siddhi Acquisition Corp (Cayman Islands) | 288.97 Mn | 288.97 Mn | - | 289.04 Mn |
| 8 | K&F Growth Acquisition | 283.42 Mn | 283.42 Mn | - | 300.60 Mn |
| 9 | Bold Eagle Acquisition | 275.29 Mn | 275.29 Mn | - | 272.82 Mn |
| 10 | Drugs Made In America Acquisition | - | - | - | 504.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 504.96 Mn |
| Sep 30, 2025 | 501.01 Mn |
| Dec 31, 2024 | 138,064.00 |